API Quick Links: http://en.hichipharm.com/

+86-152-0110-8103 yanglm@beilupharma.com

EN

EN
jp
fr
de
es
ru
pt
ar

- English
- 日本語
- français
- Deutsch
- Español
- русский
- português
- العربية

Beilu Pharmaceutical's Gadoterate Meglumine Injection Win the Bid for the 10th National Drug Centralized Procurement

2024/12/16

On December 12, 2024, Beilu Pharmaceutical participated in the bidding process for the 10th National Drug Centralized Procurement organized by the National Joint Drug Procurement Office. Beilu Pharmaceutical's Gadoterate Meglumine Injection is awarded the bid.

PREV : Beilu Pharmaceutical and Chengqingtang Traditional Chinese Medicine Establish Strategic Cooperation

NEXT : Beilu Pharma's Contrast Media Production Line Passed EU GMP Certification.

References

Related Products

Iopamidol Injection

Iopamidol Injection

Gadoterate meglumine Injection

Gadoterate meglumine Injection

Polyethylene Glycol Electrolytes Powder (Ⅲ)

Polyethylene Glycol Electrolytes Powder (Ⅲ)

Related Beilu News

【New Product】Beilu Pharmaceutical's Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets Approved
May 10, 2024Recently, Beilu Pharmaceutical received a Drug Registration Certificate from the National Medical Products Administration for Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets with a s...view
Beilu's Iopamidol Injection Won the Bid for China's Pharmaceutical Centralized Procurement
July 15, 2022On July 12, 2022, Beilu participated in the seventh batch of national centralized drug procurement organized by the National Organization for Centralized Drug Procurement and Use Joint Procurement Off...view
Beilu Pharmaceutical Plans to Acquire Tianyuan Pharmaceutical, Actively Building "Second Growth Curve"
March 1, 2024Recently, Beilu Pharmaceutical announced that it plans to use its own funds to acquire 80% of the equity of Chengde Tianyuan Pharmaceutical Co., Ltd. After the completion of this acquisition, Tianyuan...view
Beilu Pharmaceutical Has Won the
June 8, 2023Recently, the Beijing Municipal Drug Administration and the Beijing Municipal Health Commission issued a notification on "Commending Outstanding Units and Individuals in the Monitoring of Adverse...view
Congratulations: Beilu Pharma's Iodixanol Injection Passed the Consistency Evaluation for Generic Drugs
May 18, 2021Beijing Beilu Pharmaceutical Co., Ltd received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration (NMPA) on Iodixanol Injection.view
【Good News】Beilu Pharmaceutical once again honored as "Beijing Advanced Unit for Daily Monitoring of Adverse Drug Reactions"
July 11, 2024Recently, the Beijing Municipal Drug Administration and the Beijing Municipal Health Commission released a "Notification on Units and Individuals with Outstanding Performance in Drug, Medical Dev...view

Call us on:
+86-152-0110-8103
Email Us:
yanglm@beilupharma.com
No.3 Shuiyuan West Road, Miyun District, Beijing, China

Sitemap | Privacy Policy
Copyright © Beijing Beilu Pharmaceutical Co., Ltd. All Rights Reserved.

+86-152-0110-8103